Gapping down
M&A news:
- D -1.4% (Dominion Energy's Gas Transmission and Storage Business acquired by Berkshire Hathaway)
Other news:
- BLU -76.4% (announced topline results from its Phase 2 RELIEF trial of BLU-5937 in patients with refractory chronic cough)
- OBSV -6.2% (reports results from two Phase 3 studies, PRIMROSE 1 and 2, of Yselty)
- APLT -5.6% (continued pressure following short report)
- VIR -3% (announces proposed underwritten public offering of 6,200,000 shares of its common stock)
- VXX -2.9% (trading lower with US futures up over 1%)
- UIHC -1.9% (provides estimates of Q2 catastrophe losses)
- ETNB -1.8% (commences underwritten public offering of 2,200,000 shares of common stock)
- AKRO -0.8% (files for 4.75 mln share common stock offering)
Analyst comments:
- SPOT -1.5% (downgraded to Underperform from Mkt Perform at Bernstein)
- GMED -1.4% (downgraded to Neutral from Overweight at Piper Sandler)
- EVH -0.7% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)
- INTC -0.5% (downgraded to Sell from Neutral at Goldman)